PRESS RELEASE published on 05/08/2024 at 10:00, 1 year 9 months ago Sto SE & Co. KGaA: Consolidated turnover down by 5.9 % in the first quarter of 2024 compared to the same period of the previous year Sto SE & Co. KGaA reports a 5.9% decrease in consolidated turnover in Q1 2024 compared to the previous year due to weather conditions and lower investment in the building industry Financial Report Q1 2024 Sto SE & Co. KGaA Consolidated Turnover Building Industry
PRESS RELEASE published on 05/08/2024 at 09:02, 1 year 9 months ago Original-Research: Borussia Dortmund GmbH & Co KGaA (von NuWays AG): Kaufen Borussia Dortmund secures profits with UEFA advancements. Secure 5th place in Bundesliga ensures Champions League participation. Revenue decrease in Q3 prelims. Executive board changes announced. Buy recommendation with target price of EUR 5.50 Revenue Decrease Borussia Dortmund Champions League UEFA Executive Board Changes
PRESS RELEASE published on 05/08/2024 at 09:01, 1 year 9 months ago Original-Research: Westwing Group SE (von NuWays AG): Kaufen Westwing Group SE veröffentlicht starke Q1-Ergebnisse und bestätigt Jahresprognose. Positive Entwicklung von GMV und EBITDA. Aktienempfehlung: Kaufen Westwing Group SE Adj. EBITDA Q1-Ergebnisse Jahresprognose GMV-Wachstum
PRESS RELEASE published on 05/08/2024 at 09:00, 1 year 9 months ago Inside Information / Other news releases Medincell suspends listing of shares on Euronext Paris pending press release. Innovative biopharmaceutical company developing long-acting injectable drugs Euronext Paris Biopharmaceutical Suspension Medincell Long-acting Injectable Drugs
PRESS RELEASE published on 05/08/2024 at 09:00, 1 year 9 months ago Informations privilégiées / Autres communiqués Medincell suspend la cotation de ses actions sur Euronext Paris, en attente de la publication d'un communiqué. Reprise des négociations prévue demain Euronext Paris Cotation Suspension Medincell Communiqué
PRESS RELEASE published on 05/08/2024 at 08:59, 1 year 9 months ago RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter RHÖN-KLINIKUM AG reports a strong start to financial year 2024 with increased revenues and profits in Q1. The outlook for 2024 confirms positive expectations despite regulatory challenges Revenues Financial Year 2024 Outlook RHÖN-KLINIKUM AG Profits
PRESS RELEASE published on 05/08/2024 at 08:56, 1 year 9 months ago Edison issues review on Canadian General Investments (CGI): Adding to positive long-term performance record Edison issues positive review on Canadian General Investments (CGI) for its long-term performance record, highlighting strategic stock selection and dividend policy Edison Investment Research Limited Dividend Policy Canadian General Investments Long-term Performance Stock Selection
PRESS RELEASE published on 05/08/2024 at 08:50, 1 year 9 months ago Change in the Supervisory Board of DEMIRE: Ernö Theuer succeeds Prof. Dr. Kerstin Hennig DEMIRE Deutsche Mittelstand Real Estate AG announces Ernö Theuer as the new member of its Supervisory Board, succeeding Prof. Dr. Kerstin Hennig DEMIRE Deutsche Mittelstand Real Estate AG Supervisory Board Ernö Theuer CRESPI Group Prof. Dr. Kerstin Hennig
PRESS RELEASE published on 05/08/2024 at 08:31, 1 year 9 months ago Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024 Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024. Des nouvelles données seront partagées concernant le candidat médicament obefazimod Abivax Obefazimod Rectocolite Hémorragique Digestive Disease Week Cancer Du Côlon
PRESS RELEASE published on 05/08/2024 at 08:31, 1 year 9 months ago Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 Abivax presents four abstracts on obefazimod for ulcerative colitis and colon cancer model at Digestive Disease Week 2024. The company highlights novel mechanism of action and positive clinical data for obefazimod Abivax Obefazimod Ulcerative Colitis Digestive Disease Week Colon Cancer
Published on 02/08/2026 at 21:00, 6 hours 14 minutes ago Banyan Gold Extends Airstrip and High-Grade Mineralization to 350m Vertical Depth, Yukon, Canada
Published on 02/07/2026 at 01:00, 2 days 2 hours ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 2 days 4 hours ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 2 days 5 hours ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 2 days 11 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/07/2026 at 21:00, 1 day 6 hours ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 1 day 10 hours ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 1 day 10 hours ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 2 days 7 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 2 days 9 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 2 days 8 hours ago Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 2 days 8 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 2 days 11 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 2 days 11 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 2 days 19 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026